The global neurology market was valued at USD 31 billion in 2024 and grew at a CAGR of 9% from 2025 to 2034. The market is expected to reach USD 73.38 billion by 2034. The rising awareness about neurological disorders will drive the growth of the global neurology market.
The medical field dedicated to diagnosing and treating nervous system diseases of brain, spinal cord and peripheral nerves with muscles falls under the discipline of neurology. Medical specialists known as neurologists perform assessments for nervous system disorders while treating these conditions by using clinical evaluations. Neurology deals with multiple disorders among which the main ones are Alzheimer's disease, Parkinson's disease, stroke epilepsy, multiple sclerosis and migraine headaches. Neurologists cooperate with neurosurgeons, psychiatrists and rehabilitation professionals to deliver complete treatment to clients with neurological diseases. Neurology sets out to investigate the complex operations which occur inside the nervous system. Neurologists develop medical interventions that include medications combined with life-style modifications as well as physical therapy and surgery for correct analysis of patients' neurological state. The advancements in neuroscience resulted in the development of deep brain stimulation as a new procedure for specific medical conditions. The advancements in neurology pursue continual progression because new technological developments and research produce better understandings of brain and nervous system operations. The early detection and management of neurological diseases became possible due to newly developed MRI and CT scan technologies.
Get an overview of this study by requesting a free sample
Rising awareness about these conditions and technological advancements in the neuroscience – Neurological diagnostics have improved because medical technology advances brought MRI and PET scans into practice which enhance both detection accuracy and assessment capabilities of neurological disorders. Additionally, minimally invasive surgical techniques have made treatments more precise and effective thus setting forth increased demand for specialized neurological medical treatment. Personalized medicine and neurogenetics in neurology let healthcare providers create specific medical approaches which recognize individual patient genetics therefore delivering better clinical outcomes. The use of artificial intelligence (AI) in neurological diseases diagnostics and management continues to enhance service demand through efficient accurate medical evaluations. The rate of early diagnosis and heightened patient awareness functions independently as essential growth factors. The wider spread of public education about neurological disorders results in patients who recognize symptoms at an early stage and get professional medical care.
Treatments of neurological disorders are expensive – The main financial barriers alongside poor healthcare infrastructure act as constraints for the market. The main obstacle in obtaining neurological treatments stems from their high expenses. Patients with neurological disorders need sophisticated exams along with prolonged medicinal treatments combined with surgeries and therapeutic interventions which prove to be costly. The associated costs prove too expensive for numerous people who lack proper insurance coverage and enough savings. Lack of knowledge about neurological conditions along with insufficient education about these disorders reduces the number of patients who seek treatment. The population often misses neurological condition symptoms and they remain unaware about early medical attention benefits. Community assumptions linked to some neurological disorders create obstacles for patients who delay their healthcare access and fail to receive proper medical attention.
The increasing incidence of neurological disorders – The worldwide aging population represents the rising incidence of neurological disordered because older adults have higher susceptibility to neurological dementia and Parkinson's disease and stroke. Life expectancy growth results in increased occurrences of these conditions which fuels the requirement for concentrated neurology medical care. Lifestyle choices that combine stress, unhealthy eating habits and absence of physical activity leads to higher rates of migraines epilepsy and strokes because these health conditions require additional neurology service provision. Improvements in healthcare infrastructure together with specialized medical facilities growth and trained professional availability leads to enhanced accessibility of neurology care in numerous regions. The increased accessibility of treatment enables many new groups of patients to receive care particularly in underdeveloped countries. The increase in health insurance coverage for neurological medical services has simultaneously lowered their costs and improved access thus more patients can receive neurological care.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global neurology market, with a 42% market revenue share in 2024.
One of the most affected regions worldwide concerning neurological conditions exists in the United States where it encounters elevated occurrences of Alzheimer’s disease alongside Parkinson’s disease and epilepsy and these numbers increase given the aging demographic. The expanding base of neurological patients requires a substantial amount of specialized neurology care and diagnostic services and treatment solutions. North American healthcare facilities operate through advanced medical equipment such as MRI scan and PET scan machines and advanced electrophysiological monitoring tools in their medical centres and hospitals. The medical facilities within North America deliver complete neurological care to their patients by providing advanced services from diagnosis through medical treatment to rehabilitation programs to maintain their regional leadership role. The neurological drug development market is advanced by leading pharmaceutical and biotech companies along with their continuous discoveries, innovations and scientific breakthroughs. The region benefits from extensive research independently conducted by governmental institutions and other private entities as well as universities.
North America Region Neurology Market Share in 2024 - 42%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The type of neurological disorder segment is divided into neurodegenerative diseases, cerebrovascular disorders, epileptic disorders, demyelinating diseases, headache disorders, neuromuscular disorders and others. The neurodegenerative diseases segment dominated the market, with a market share of around 38% in 2024. Alzheimer’s disease, the most common form of dementia, and Parkinson’s disease, a progressive movement disorder, represent major public health concerns, with millions of people worldwide affected. An ample market demand exists because consistent medical intervention is needed for managing symptoms and slowing disease progression. Alzheimer's disease treatment requires disease-modifying therapies that medical professionals heavily seek while Parkinson's disease patients mostly require treatments for symptom management including tremor control and motor dysfunction improvement. Neurodegenerative diseases impose substantial financial strain on healthcare systems because they require extensive patient care so pharmaceutical companies along with healthcare providers maintain this segment as their main focus. Future research directions about disease mechanisms and medication development will sustain the prevalence of neurodegenerative diseases across the neurology market. These conditions will drive market expansion because they exist in high numbers and require expensive care for extended periods.
The treatment type segment is divided into pharmaceuticals, surgical treatments, diagnostics, therapies and others. The pharmaceuticals segment dominated the market, with a market share of around 37% in 2024. Medical drugs serve essential purposes in neurology treatment by managing symptoms alongside slowing disease advancement and enhancing patient health conditions. There exist disease-modifying therapies (DMTs) that serve as primary treatment options for Alzheimer’s and Parkinson’s disease because they work to stop or delay the progression of these serious conditions. Medications known as antiepileptic drugs function as the core treatment against seizures in epilepsy while specific drugs including triptans and preventive therapies help manage the widespread condition of migraines. The development of molecular biology along with neurogenetics and biopharmaceuticals has led to new therapeutic drugs that match individual genetic characteristics thus producing enhanced efficiency with reduced adverse effects. Pharmaceutical companies dedicate abundant financial resources to neurology R&D because neurological diseases are increasingly prevalent while healthcare professionals seek imperative new treatment methods. Pharmaceuticals play a critical role in prolonged neurology care because most neurological conditions persist for extended periods thus requiring long-term treatment options for both disease modification and symptom control. Neurology market expansion and innovation will continue under advanced pharmaceutical research and drug delivery system developments.
The end user segment is divided into hospitals, neurology clinics, ambulatory surgical centers (ASCs), research institutes and others. The hospitals segment dominated the market, with a market share of around 42% in 2024. A hospital offers its patients access to a comprehensive array of diagnosis and treatment solutions at one place. Hospitals offer a complete healthcare atmosphere that allows neurologists neurosurgeons and nurses together with rehabilitation specialists to jointly manage patient care. A team-based care model provides patients with all necessary medical services beginning with diagnosis and extending to treatment as well as rehabilitation and ongoing healthcare follow-ups. Healthcare improvements have solidified hospitals as the primary centres for specialized neurological care thus establishing them as essential institutions for managing these extensive medical issues. The global neurology market largely depends on hospitals because of specialized treatment needs and advanced technology which will sustain their dominant position in serving both acute and chronic neurological needs.
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2024 | USD 31 Billion |
Market size value in 2034 | USD 73.38 Billion |
CAGR (2025 to 2034) | 9% |
Historical data | 2021-2023 |
Base Year | 2024 |
Forecast | 2025-2034 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Type of Neurological Disorder, Treatment Type and End User |
As per The Brainy Insights, the size of the global neurology market was valued at USD 31 billion in 2024 to USD 73.38 billion by 2034.
Global neurology market is growing at a CAGR of 9% during the forecast period 2025-2034.
The market's growth will be influenced by rising awareness about these conditions and technological advancements in the neuroscience.
Treatments of neurological disorders are expensive could hamper the market growth.
This study forecasts revenue at global, regional, and country levels from 2021 to 2034. The Brainy Insights has segmented the global neurology market based on below mentioned segments:
Global Neurology Market by Type of Neurological Disorder:
Global Neurology Market by Treatment Type:
Global Neurology Market by End User:
Global Neurology Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date